A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
When standard leukaemia treatments failed, 13-year-old Alyssa Tapley was told she had only weeks left – but then she was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results